Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction

Journal of Lipid Research(2025)10.1016/j.jlr.2025.100800Source: DataRank Database

Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction is a research paper published in Journal of Lipid Research (2025). On theSindex it has a DataRank of 0.406. It has been cited 14 times.

N/A

0.406DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 14.98)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.406

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (64)

Kevin Huynh ORCID,Yvette L. Schooneveldt ORCID,Gavriel Olshansky ORCID,Amy Liang,Tingting Wang ORCID

Live enrichment

PubMed:40216335 PMC:PMC12139500 OpenAlex:https://openalex.org/W4409323097

National Health and Medical Research Council

Grant: APP1101320

National Health and Medical Research Council

Grant: 211086

A factorial randomised trial of intensive blood pressure lowering and glucose control in subjects with type 2 diabetes.

National Health and Medical Research Council

Grant: 358395

New evidence to guide decisions about the prevention and treatment of common cardiovascular diseases.

National Health and Medical Research Council

Grant: R01 DK127636

National Institutes of Health

Grant: R01 HL140681

National Institutes of Health

Grant: R01 MH078143

NIMH NIH HHS

Grant: R01 MH083824

NHLBI NIH HHS

Grant: P01 HL045522

National Institutes of Health

Grant: R01 MH078111

State Government of Victoria

Bristol-Myers Squibb

FWCI

14.98

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.jlr.2025.100800

GOLDhttps://doi.org/10.1016/j.jlr.2025.100800

publisherhttps://doi.org/10.1016/j.jlr.2025.100800

publisherhttps://api.elsevier.com/content/article/PII:S0022227525000604?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022227525000604?httpAccept=text/plain

Fields of Study

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCancer, Lipids, and MetabolismMedicine03 medical and health sciences0302 clinical medicineHydroxymethylglutaryl-CoA Reductase InhibitorsHumansCardiovascular DiseasesLipidomicsMaleFemaleHeart Disease Risk Factors

MeSH Terms

LipidomicsHeart Disease Risk FactorsCardiovascular DiseasesFemaleHumansMaleHydroxymethylglutaryl-CoA Reductase Inhibitors

Keywords

LipidomeStatinHydroxymethylglutaryl-CoA Reductase InhibitorsRosuvastatinCholesterolLipidomicsMedicineComputational biologyInternal medicineBioinformaticsBiologyCardiovascular diseasestatinsRegularized Linear ModelsMaleQD415-436BiochemistryCardiovascular DiseasesHeart Disease Risk FactorsHumansFemaleResearch Article